Advertisement

Role of multimodality imaging in the early identification of cardiac sarcoidosis

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

References

  1. 1.

    Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.

  2. 2.

    Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of F-18 FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and meta-analysis including the Ontario experience. J Nucl Med 2012;53:241-8.

  3. 3.

    Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008;35:933-41.

Download references

Conflict of interest

The authors have indicated that they have no financial conflict of interest.

Author information

Correspondence to Hanna N. Ahmed MD, MPH.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (MP4 176 kb)

Supplementary material 1 (M4V 875 kb)

Supplementary material 1 (MP4 176 kb)

Supplementary material 1 (M4V 875 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ahmed, H.N., Paz, Y.E., Stuck, J. et al. Role of multimodality imaging in the early identification of cardiac sarcoidosis. J. Nucl. Cardiol. 21, 655–659 (2014). https://doi.org/10.1007/s12350-014-9856-x

Download citation

Keywords

  • Sarcoidosis
  • Cardiac Involvement
  • Multiple Imaging
  • Endomyocardial Biopsy
  • Multimodality Imaging